LONDON (Reuters) - Treating COVID-19 patients at home with a commonly-used inhaled asthma drug called budesonide can speed up their recovery, according to UK trial results on Monday which doctors said ...

Young woman using asthma inhaler at home. The NDA submission is supported by data from the phase 3 MANDALA trial, which included 3132 patients with moderate to severe asthma. The Food and Drug ...

Another steroid has been found to prevent serious COVID, but this one is different. Unlike dexamethasone, which is a systemic steroid, budesonide, a drug commonly used for asthma, is dosed directly to ...

Budesonide has been touted as a "silver bullet" for treating COVID-19 by one West Texas doctor, but many other doctors say the drug needs to be studied before it's widely used. (KSAT) SAN ANTONIO – A ...

AS VACCINATION against covid-19 gathers speed, the end of the covid-19 pandemic is starting to hover on the horizon. But not everyone will take the vaccine and none of the jabs is 100% effective at ...

PHILADELPHIA Patients with stage 3 or 4 melanoma taking ipilimumab (a human monoclonal antibody being developed by Bristol-Myers Squibb and Medarex) and the oral steroid budesonide to reduce side ...

Please provide your email address to receive an email when new articles are posted on . The complete response letter (CRL) denied approval for budesonide oral suspension (BOS) and recommended ...

Treating COVID-19 patients at home with a commonly-used inhaled asthma drug called budesonide can speed up their recovery, according to UK trial results on Monday which doctors said could change the ...